| |
| |
|
| Insider
Information: |
Wagner Charles F Jr |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Billerica |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
234,683 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,362,044 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
234,683 |
|
|
| Total
Value |
$35,362,044 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progress Software Corp |
PRGS |
EVP Finance & Admin an... |
2011-10-14 |
81,175 |
|
0 |
Premium* |
|
|
Bruker Corp |
BRKR |
EVP & Chief Financial ... |
2015-03-17 |
99,925 |
2012-08-02 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP & Chief Financial ... |
2024-02-23 |
53,583 |
2019-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGS |
Progress Software Corp |
EVP Finance & Admin and CFO |
• – – |
2011-10-14 |
4 |
A |
$20.73 |
$518,250 |
D/D |
25,000 |
81,175 |
0 |
- |
|
| BRKR |
Bruker Corp |
EVP & Chief Financial Officer |
• – – |
2012-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
88,028 |
88,028 |
0 |
- |
|
| BRKR |
Bruker Corp |
EVP & Chief Financial Officer |
• – – |
2013-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
25,726 |
106,568 |
0 |
- |
|
| BRKR |
Bruker Corp |
EVP & Chief Financial Officer |
• – – |
2014-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,895 |
121,987 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CFO |
• – – |
2019-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,697 |
3,697 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CFO |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,021 |
17,816 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,951 |
38,138 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,588 |
60,379 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,026 |
72,890 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,254 |
58,947 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,114 |
66,061 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2020-07-10 |
4 |
AS |
$291.19 |
$205,206 |
D/D |
(700) |
16,126 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-02-02 |
4 |
AS |
$250.07 |
$736,206 |
D/D |
(2,944) |
57,435 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-03-17 |
4 |
AS |
$250.13 |
$793,218 |
D/D |
(3,171) |
46,202 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-04-01 |
4 |
AS |
$261.42 |
$683,602 |
D/D |
(2,582) |
43,620 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-05-02 |
4 |
AS |
$254.87 |
$88,778 |
D/D |
(343) |
42,730 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-10 |
4 |
AS |
$286.64 |
$604,709 |
D/D |
(2,088) |
56,045 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-13 |
4 |
AS |
$288.31 |
$783,346 |
D/D |
(2,666) |
53,379 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-17 |
4 |
AS |
$294.52 |
$592,786 |
D/D |
(2,000) |
51,379 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-24 |
4 |
AS |
$305.38 |
$539,912 |
D/D |
(1,768) |
49,611 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-11-20 |
4 |
AS |
$349.88 |
$1,049,640 |
D/D |
(3,000) |
46,693 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-01-02 |
4 |
AS |
$405.00 |
$1,215,000 |
D/D |
(3,000) |
43,693 |
0 |
% |
|
| PRGS |
Progress Software Corp |
EVP Finance & Admin and CFO |
• – – |
2011-04-01 |
4 |
D |
$29.53 |
$75,112 |
D/D |
(2,544) |
45,456 |
0 |
- |
|
| BRKR |
Bruker Corp |
EVP & Chief Financial Officer |
• – – |
2013-08-02 |
4 |
D |
$19.93 |
$143,217 |
D/D |
(7,186) |
80,842 |
0 |
- |
|
| BRKR |
Bruker Corp |
EVP & Chief Financial Officer |
• – – |
2014-08-02 |
4 |
D |
$22.40 |
$234,662 |
D/D |
(10,476) |
96,092 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
